Titre : | The global cannabis report: 3rd Edition |
Auteurs : | Prohibition Partners |
Type de document : | Rapport |
Mention d'édition : | 3rd Edition |
Editeur : | London : Prohibition Partners, 2022 |
Format : | 88 p. |
Langues: | Anglais |
Discipline : | MAR (Marchés / Markets) |
Mots-clés : |
Thésaurus mots-clés CANNABIS ; CANNABIDIOL ; LEGALISATION ; MARCHE DE LA DROGUE ; USAGE THERAPEUTIQUE ; USAGE RECREATIF ; LEGISLATION ; COMMERCE ; PRODUCTIONThésaurus géographique INTERNATIONAL |
Résumé : |
Prohibition Partners estimates that, in 2022, the global sales of CBD, medical and adult-use cannabis amounted to US$45 billion and could be worth more than US$101 billion by 2026.
2022 was another massive year for the development of progressive policy on cannabis control globally. Legalisation of high THC cannabis for non-medical purposes will soon be a reality in several countries around the world. Decriminalisation of adult-use cannabis is also progressing globally, which may be a precursor to commercial legalisation in some regions. In Latin America, both Costa Rica and Panama adopted their medical cannabis laws for the first time in 2022. In Europe, the Spanish government legalised the magistral use of medical cannabis for select conditions through the country's public health system in June 2022. Over in Asia, Malaysia has stated their intention to legalise medicinal cannabis, taking inspiration from Thailand. |
Domaine : | Autres substances / Other substances ; Drogues illicites / Illicit drugs |
Affiliation : | UK |
Lien : | https://prohibitionpartners.com/reports/the-global-cannabis-report-edition-3/ |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil